| Symbol |
Name |
|
ABCA4
|
ATP-binding cassette, sub-family A (ABC1), member 4
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABO
|
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
|
|
ACTB
|
actin, beta
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AHSA1
|
AHA1, activator of heat shock 90kDa protein ATPase homolog 1 (yeast)
|
|
AIMP2
|
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
AMELX
|
amelogenin, X-linked
|
|
AMH
|
anti-Mullerian hormone
|
|
ANXA1
|
annexin A1
|
|
ANXA6
|
annexin A6
|
|
APRT
|
adenine phosphoribosyltransferase
|
|
AQP4
|
aquaporin 4
|
|
ARID1B
|
AT rich interactive domain 1B (SWI1-like)
|
|
ARNTL
|
aryl hydrocarbon receptor nuclear translocator-like
|
|
ATM
|
ATM serine/threonine kinase
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BEX2
|
brain expressed X-linked 2
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
C1QBP
|
complement component 1, q subcomponent binding protein
|
|
CANX
|
calnexin
|
|
CASK
|
calcium/calmodulin-dependent serine protein kinase (MAGUK family)
|
|
CBR1
|
carbonyl reductase 1
|
|
CCDC8
|
coiled-coil domain containing 8
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL24
|
chemokine (C-C motif) ligand 24
|
|
CCL26
|
chemokine (C-C motif) ligand 26
|
|
CCN2
|
cellular communication network factor 2
|
|
CCND1
|
cyclin D1
|
|
CD8A
|
CD8a molecule
|
|
CDCA5
|
cell division cycle associated 5
|
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35)
|
|
CDK7
|
cyclin-dependent kinase 7
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDX2
|
caudal type homeobox 2
|
|
CHPT1
|
choline phosphotransferase 1
|
|
CIP2A
|
cellular inhibitor of PP2A
|
|
CLN3
|
ceroid-lipofuscinosis, neuronal 3
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COX1
|
|
|
COX2
|
|
|
CRK
|
v-crk avian sarcoma virus CT10 oncogene homolog
|
|
CRTC1
|
CREB regulated transcription coactivator 1
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
DBH
|
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
|
|
DCTN6
|
dynactin 6
|
|
DCX
|
doublecortin
|
|
DDIT4
|
DNA-damage-inducible transcript 4
|
|
DECR1
|
2,4-dienoyl CoA reductase 1, mitochondrial
|
|
DEPDC5
|
DEP domain containing 5
|
|
DHDDS
|
dehydrodolichyl diphosphate synthase
|
|
DKK1
|
dickkopf WNT signaling pathway inhibitor 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
ELOC
|
elongin C
|
|
EPHB2
|
EPH receptor B2
|
|
EREG
|
epiregulin
|
|
FCN2
|
ficolin (collagen/fibrinogen domain containing lectin) 2
|
|
FLCN
|
folliculin
|
|
FLNA
|
filamin A, alpha
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FMR1
|
fragile X mental retardation 1
|
|
FUZ
|
fuzzy planar cell polarity protein
|
|
GABPA
|
GA binding protein transcription factor, alpha subunit 60kDa
|
|
GC
|
group-specific component (vitamin D binding protein)
|
|
GCHFR
|
GTP cyclohydrolase I feedback regulator
|
|
GCLC
|
glutamate-cysteine ligase, catalytic subunit
|
|
GFAP
|
glial fibrillary acidic protein
|
|
GH1
|
growth hormone 1
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GLRX3
|
glutaredoxin 3
|
|
GNA11
|
guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
|
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12
|
|
GPT
|
glutamic-pyruvate transaminase (alanine aminotransferase)
|
|
GRAP2
|
GRB2-related adaptor protein 2
|
|
GRHL3
|
grainyhead-like 3 (Drosophila)
|
|
GRIN2C
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2C
|
|
GRM5
|
glutamate receptor, metabotropic 5
|
|
GRN
|
granulin
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
HCRT
|
hypocretin (orexin) neuropeptide precursor
|
|
HEXDC
|
hexosaminidase (glycosyl hydrolase family 20, catalytic domain) containing
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HMBS
|
hydroxymethylbilane synthase
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HTR2C
|
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IFI27
|
interferon, alpha-inducible protein 27
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL12A
|
interleukin 12A
|
|
IL17A
|
interleukin 17A
|
|
IL1B
|
interleukin 1, beta
|
|
IL21
|
interleukin 21
|
|
IL21R
|
interleukin 21 receptor
|
|
IL22
|
interleukin 22
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
ING2
|
inhibitor of growth family, member 2
|
|
INHA
|
inhibin, alpha
|
|
IRF7
|
interferon regulatory factor 7
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
KIF1A
|
kinesin family member 1A
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LAMC2
|
laminin, gamma 2
|
|
LAT
|
linker for activation of T cells
|
|
LIG4
|
ligase IV, DNA, ATP-dependent
|
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2
|
|
LINGO1
|
leucine rich repeat and Ig domain containing 1
|
|
LOC101060233
|
medium-wave-sensitive opsin 1
|
|
LOC105375355
|
uroplakin-3b
|
|
LRPPRC
|
leucine-rich pentatricopeptide repeat containing
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MARCH10
|
membrane-associated ring finger (C3HC4) 10, E3 ubiquitin protein ligase
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MFAP1
|
microfibrillar-associated protein 1
|
|
MLYCD
|
malonyl-CoA decarboxylase
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MNAT1
|
MNAT CDK-activating kinase assembly factor 1
|
|
MPP2
|
membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTTP
|
microsomal triglyceride transfer protein
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYO1B
|
myosin IB
|
|
NES
|
nestin
|
|
NEUROG2
|
neurogenin 2
|
|
NF1
|
neurofibromin 1
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NGFRAP1
|
nerve growth factor receptor (TNFRSF16) associated protein 1
|
|
NOTCH1
|
notch 1
|
|
NOX4
|
NADPH oxidase 4
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NTF3
|
neurotrophin 3
|
|
NTF4
|
neurotrophin 4
|
|
OGA
|
O-GlcNAcase
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OPN1MW
|
opsin 1 (cone pigments), medium-wave-sensitive
|
|
OPN1MW2
|
opsin 1 (cone pigments), medium-wave-sensitive 2
|
|
OPN1SW
|
opsin 1 (cone pigments), short-wave-sensitive
|
|
ORAI1
|
ORAI calcium release-activated calcium modulator 1
|
|
PAH
|
phenylalanine hydroxylase
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PAM
|
peptidylglycine alpha-amidating monooxygenase
|
|
PARK7
|
parkinson protein 7
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDCD1
|
programmed cell death 1
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PEX13
|
peroxisomal biogenesis factor 13
|
|
PHLPP1
|
PH domain and leucine rich repeat protein phosphatase 1
|
|
PIK3C3
|
phosphatidylinositol 3-kinase, catalytic subunit type 3
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CB
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIM3
|
Pim-3 proto-oncogene, serine/threonine kinase
|
|
PITX1
|
paired-like homeodomain 1
|
|
PKD1
|
polycystic kidney disease 1 (autosomal dominant)
|
|
PLA2G1B
|
phospholipase A2, group IB (pancreas)
|
|
PLB1
|
phospholipase B1
|
|
PLCD1
|
phospholipase C, delta 1
|
|
PLG
|
plasminogen
|
|
POLDIP2
|
polymerase (DNA-directed), delta interacting protein 2
|
|
POMC
|
proopiomelanocortin
|
|
PPP1R15A
|
protein phosphatase 1, regulatory subunit 15A
|
|
PRDX1
|
peroxiredoxin 1
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKD1
|
protein kinase D1
|
|
PRRX1
|
paired related homeobox 1
|
|
PSMD9
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 9
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS1
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTPN4
|
protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte)
|
|
PVALB
|
parvalbumin
|
|
RABGEF1
|
RAB guanine nucleotide exchange factor (GEF) 1
|
|
RALGAPB
|
Ral GTPase activating protein, beta subunit (non-catalytic)
|
|
RAP1A
|
RAP1A, member of RAS oncogene family
|
|
RAP1GAP
|
RAP1 GTPase activating protein
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RBBP4
|
retinoblastoma binding protein 4
|
|
RGS6
|
regulator of G-protein signaling 6
|
|
RHEB
|
Ras homolog enriched in brain
|
|
RIPK2
|
receptor-interacting serine-threonine kinase 2
|
|
RMDN1
|
regulator of microtubule dynamics 1
|
|
RMDN2
|
regulator of microtubule dynamics 2
|
|
RMDN3
|
regulator of microtubule dynamics 3
|
|
RNF19A
|
ring finger protein 19A, RBR E3 ubiquitin protein ligase
|
|
RPGRIP1L
|
RPGRIP1-like
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
|
S100A1
|
S100 calcium binding protein A1
|
|
S100B
|
S100 calcium binding protein B
|
|
SDC2
|
syndecan 2
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SGSM3
|
small G protein signaling modulator 3
|
|
SHOX
|
short stature homeobox
|
|
SLC12A2
|
solute carrier family 12 (sodium/potassium/chloride transporter), member 2
|
|
SLC12A3
|
solute carrier family 12 (sodium/chloride transporter), member 3
|
|
SLC12A5
|
solute carrier family 12 (potassium/chloride transporter), member 5
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SSSCA1
|
Sjogren syndrome/scleroderma autoantigen 1
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STIM1
|
stromal interaction molecule 1
|
|
STK11
|
serine/threonine kinase 11
|
|
SYBU
|
syntabulin (syntaxin-interacting)
|
|
TBC1D7
|
TBC1 domain family, member 7
|
|
TBC1D9
|
TBC1 domain family, member 9 (with GRAM domain)
|
|
TCOF1
|
Treacher Collins-Franceschetti syndrome 1
|
|
TERF2IP
|
telomeric repeat binding factor 2, interacting protein
|
|
TESC
|
tescalcin
|
|
TFRC
|
transferrin receptor
|
|
TICAM2
|
toll-like receptor adaptor molecule 2
|
|
TLR7
|
toll-like receptor 7
|
|
TMED7
|
transmembrane emp24 protein transport domain containing 7
|
|
TMED7-TICAM2
|
TMED7-TICAM2 readthrough
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TP53
|
tumor protein p53
|
|
TRIM31
|
tripartite motif containing 31
|
|
TRPC4
|
transient receptor potential cation channel, subfamily C, member 4
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TYMS
|
thymidylate synthetase
|
|
TYR
|
tyrosinase
|
|
UBASH3B
|
ubiquitin associated and SH3 domain containing B
|
|
UTS2
|
urotensin 2
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VIM
|
vimentin
|
|
WDR45
|
WD repeat domain 45
|
|
WDR45B
|
WD repeat domain 45B
|
|
WNT3A
|
wingless-type MMTV integration site family, member 3A
|
|
YWHAB
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
